Skip to content
ScreenTX
Home
About Us
Science
Approach
Pipeline
Media
Contact Us
Home
About Us
Science
Approach
Pipeline
Media
Contact Us
Media
Presentations
Oct, 2014 – Envisage LLC – founded in 2014 to identify, create and advanced broad spectrum, immunology drug targets.
To view our 2014 presentation click here:
Envisage LLC – Pharma_non_confidential_October 2014
March, 2015 – Envisage LLC selects targets of interest.
To v
iew our 2015 presentation click here:
Mar 22 2015_Envisage LLC – Organic-Immuno Asset Presentation_Confidential_March 2015.
Press Releases
News Article
Date
Screen Therapeutics Announces Preliminary Findings on Targeting LAIR-1 and Other ECM Proteins
March 01, 2022
Screen Therapeutics enters into an immuno-oncology drug development partnership with Immunaccel
December 05, 2019
ENVISAGE and the Wistar Institute forge new venture and value creation partnership
March 10, 2015
March 1, 2022
–
Screen Therapeutics Announces Preliminary Findings on Targeting LAIR-1 and Other ECM Proteins
December, 2019 –
Screen Therapeutics enters into an immuno-oncology drug development partnership with Immunaccel
March, 2015 –
ENVISAGE and the Wistar Institute forge new venture and value creation partnership
Go to Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
